These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8867919)

  • 21. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
    Popik P; Kozela E
    Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors.
    Mehta AK; Halder S; Khanna N; Tandon OP; Sharma KK
    Hum Exp Toxicol; 2012 Jan; 31(1):51-6. PubMed ID: 21803783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
    Holtman JR; Jing X; Wala EP
    Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model.
    Neyama H; Dozono N; Ueda H
    J Pharmacol Exp Ther; 2020 Apr; 373(1):103-112. PubMed ID: 31941720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
    Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
    Bulka A; Wiesenfeld-Hallin Z; Xu XJ
    Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine.
    Van Elstraete AC; Sitbon P; Trabold F; Mazoit JX; Benhamou D
    Anesth Analg; 2005 Dec; 101(6):1750-1756. PubMed ID: 16301254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.
    Bespalov A; Kudryashova M; Zvartau E
    Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus.
    Caudle RM; Dubner R
    Neuropeptides; 1998 Feb; 32(1):87-95. PubMed ID: 9571650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation.
    Shen L; Wang W; Li S; Qin J; Huang Y
    Mol Brain; 2018 Jun; 11(1):35. PubMed ID: 29954440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. μ-Opioid and N-methyl-D-aspartate receptors in the amygdala contribute to minocycline-induced potentiation of morphine analgesia in rats.
    Ghazvini H; Rezayof A; Ghasemzadeh Z; Zarrindast MR
    Behav Pharmacol; 2015 Jun; 26(4):383-92. PubMed ID: 25563202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
    Bredeloux P; Costentin J; Dubuc I
    Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
    Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
    Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.